EUVIMEDEUVIMED entdecken
Crossref

Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study

Noomane Bouaziz, Charles Laidi, Samuel Bulteau, Caroline Berjamin, Fanny Thomas, Virginie Moulier, René Benadhira, David Szekely, Emmanuel Poulet, Filipe Galvao, Olivier Guillin, Marie-Carmen Castillo und 5 weitere

Journal of Affective Disorders · 2023-04 · 326 · 26-35

DOI: 10.1016/j.jad.2023.01.070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023-04. Verfasst von Noomane Bouaziz und 16 weiteren Autor:innen. Beteiligte Einrichtung: EPS Ville Evrard, Pôle 93G03, Centre de Recherche Clinique, Neuilly-sur-Marne, France.; La Fondation FondaMental, F-94010 Créteil, France. Electronic…. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In 2008, the U.S. FDA approved rTMS as a treatment against medication-resistant depression. However, real-world rTMS outcomes remain understudied. This study investigates how rTMS for depression is delivered in routine clinical practice in France, and measures its effectiveness as well as its moderators. METHODS: Five centers provided retrospective data on patients who were treated with rTMS for treatment-resistant depression from January 2015 to December 2020. Patients were assessed twice using a hetero-questionnaire, with baseline and immediate post-treatment assessments. We conducted univariate analyses to study which factors were significantly associated with rTMS effectiveness. We then included age, gender, and significant factors in a multivariate model. RESULTS: We collected data from 435 patients with a mean age of 51.27 (14.91): 66 % were female, and 26 % suffered from bipolar depression. Stimulation was delivered using four different stimulation parameters: 1 Hz (7 % of the individuals), 10 Hz (43 %), 20 Hz (12 %), and 50 Hz (intermittent Theta Burst Stimulation, iTBS) (38 %). The mean improvement of depressive symptoms was 33 % (p < 0.001, effect-size: 0.79). Response and remission rates were of 31 % and 22.8 %, respectively. In the multivariate analysis, improvement in depressive symptoms was associated with higher baseline symptoms. CONCLUSION: This is one of the largest studies that investigates, with careful clinician-rated scales by trained psychiatrists, the effect of rTMS in naturalistic settings. Repetitive TMS appears to be effective in routine clinical practice, although its efficacy could be improved by analyzing predictors of response, as well as personalized targeting of specific brain areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderHumansFemaleMiddle AgedMaleTranscranial Magnetic StimulationRetrospective StudiesDepressionBrainTreatment OutcomePrefrontal Cortex

Stichwörter der Autor:innen

NIBSNaturalistic studyTreatment resistant depressionrTMS

Autor:innen und Institutionen

  • EPS Ville Evrard, Pôle 93G03, Centre de Recherche Clinique, Neuilly-sur-Marne, France.; La Fondation FondaMental, F-94010 Créteil, France. Electronic address: n.bouaziz@epsve.fr.
  • La Fondation FondaMental, F-94010 Créteil, France; Pôle de Psychiatrie, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine de Créteil, DMU IMPACT, Hôpitaux Universitaires Mondor, Créteil, France.
  • CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.
  • University Department of Psychiatry, Centre d'Excellence Thérapeutique-Institut de Psychiatrie-Centre Hospitalier du Rouvray, Sotteville-lès-Rouen, France.
  • EPS Ville Evrard, Pôle 93G03, Centre de Recherche Clinique, Neuilly-sur-Marne, France.
  • EPS Ville Evrard, Pôle 93G03, Centre de Recherche Clinique, Neuilly-sur-Marne, France.; University Department of Psychiatry, Centre d'Excellence Thérapeutique-Institut de Psychiatrie-Centre Hospitalier du Rouvray, Sotte…

Zitieren

APA

Bouaziz, N., Laidi, C., Bulteau, S., Berjamin, C., Thomas, F., Moulier, V., Benadhira, R., Szekely, D., Poulet, E., Galvao, F., Guillin, O., Castillo, M. C., Sauvaget, A., Plaze, M., Januel, D., Brunelin, J., & Rotharmel, M. (2023). Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study. Journal of Affective Disorders, 326, 26-35. https://doi.org/10.1016/j.jad.2023.01.070

Vancouver

Bouaziz N, Laidi C, Bulteau S, Berjamin C, Thomas F, Moulier V, et al. Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study. Journal of Affective Disorders. 2023;326:26-35. doi:10.1016/j.jad.2023.01.070

BibTeX
@article{Bouaziz2023,
  author = {Bouaziz, Noomane and Laidi, Charles and Bulteau, Samuel and Berjamin, Caroline and Thomas, Fanny and Moulier, Virginie and Benadhira, René and Szekely, David and Poulet, Emmanuel and Galvao, Filipe and Guillin, Olivier and Castillo, Marie-Carmen and Sauvaget, Anne and Plaze, Marion and Januel, Dominique and Brunelin, Jérôme and Rotharmel, Maud},
  title = {Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study},
  journal = {Journal of Affective Disorders},
  year = {2023},
  volume = {326},
  pages = {26--35},
  doi = {10.1016/j.jad.2023.01.070}
}
Kostenlos starten →